Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase
Open Access
- 26 November 2014
- journal article
- Published by Springer Nature in BMC Microbiology
- Vol. 14 (1) , 1-11
Abstract
Human immunodeficiency virus type 1 (HIV-1) Vif hijacks an E3 ligase to suppress natural APOBEC3 restriction factors, and core binding factor β (CBF-β) is required for this process. Although an extensive region of Vif spanning most of its N-terminus is known to be critical for binding with CBF-β, involvement of the Vif C-terminus in the interaction with CBF-β has not been fully investigated. Here, through immunoprecipitation analysis of Vif C-terminal truncated mutants of various lengths, we identified that CBF-β binding requires not only certain amino acids (G126A, E134A, Y135A and G138A) in the HCCH region but also the HCCH motif itself, which also affects the Vif-mediated suppression of APOBEC3G/APOBEC3F (A3G/A3F). These mutants still maintained interactions with substrate A3G or A3F as well as other cellular factors ElonginB/C (ELOB/C), indicating that their structures were not functionally affected. Moreover, by determining that the BC box also is necessary for CBF-β interaction in vivo, we speculate that binding to ELOB/C induces conformational changes in Vif, facilitating its interaction with CBF-β and consequent interaction with CUL5. These results provide important information on the assembly of the Vif-CUL5-E3 ubiquitin ligase. Identification of the new binding interface with CBF-β at the C-terminus of HIV-1 Vif also provides novel targets for the development of HIV-1 inhibitors.Keywords
This publication has 56 references indexed in Scilit:
- Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infectionNature, 2011
- Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeuticsExpert Reviews in Molecular Medicine, 2010
- Multiple ways of targeting APOBEC3–virion infectivity factor interactions for anti-HIV-1 drug developmentTrends in Pharmacological Sciences, 2009
- Molecular Structure and Biochemical Properties of the HCCH−Zn2+ Site in HIV-1 VifBiochemistry, 2009
- Sole copy of Z2‐type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV‐1.The FASEB Journal, 2008
- Characterization of Conserved Motifs in HIV-1 Vif Required for APOBEC3G and APOBEC3F InteractionJournal of Molecular Biology, 2008
- Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminasesCellular Microbiology, 2008
- Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein–protein interactionsProceedings of the National Academy of Sciences, 2006
- Cytidine Deamination of Retroviral DNA by Diverse APOBEC ProteinsCurrent Biology, 2004
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002